1Tannuri U,Velhote MC,Santos MM,et al.Pediatric liver transplantation:fourteen years of experience at the children institute in Sao Paulo,Brazil[J].Transplant Proc,2004,36(4):941-942.
2Wang YL,Zhang YY,Zhou YL,et al.T-helper and T-cytotoxic cell subsets monitoring during activecytomegalovirus infection in liver transplantation[J].Transplant Proc,2004,36(5):1498-1499.
3Brown RS Jr.Is recurrence of hepatitis C worse after living donor or deceased donor liver transplantation[J]?Liver Transpl,2004,10(10):1256-1257.
4Moreno S,Fortun J,Quereda C,at al.Liver transplantation in HIV-infected recipients[J].Liver Transpl,2005,11(1):76-81.
5Stadlbauer V,Schaffellner S,Kniepeiss D,et al.Experiences in liver transplantation for hepatocellular carcinoma[J].Transplant Proc,2004,36(1):195-198.
6Miyagawa-Hayashino A,Haga H,Egawa H,et al.Outcome and risk factors of De Novo autoimmunehepatitis in living-donor liver transplantation[J].Transplantation,2004,78(1):128-135.
7Goodman J,Glasgow SC,Schnitzler M,et al.Liver transplantation for hepatocellular carcinoma:Expanding special priority to include stage III disease[J].Arch Surg,2005,140(5):459-464.
8Yedibela S,Fortsch T,Hohenberger W,et al.Liver transplantation for hepatocellular carcinoma:a single European centre experience[J].Langenbecks Arch Surg,2004,389(2):104-109.
9Maheshwari A,Yoo HY,Thuluvath PJ.Long-term outcome of liver transplantation in patients with PSC:A comparative analysis with PBC[J].Am J Gastroenterol,2004,99(3):538-542.
10Yedibela S,Reck T,Niedobitek G,et al.Anti-CD20 monoclonal antibody treatment of Epstein-Barr virus-induced intrahepatic lymphoproliferative disorder following liver transplantation[J].Transpl Int,2003,16(3):197-201.
3Abed N,Casper JT,Camitta BM,et al.Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders[J].Bone Marrow Transplant,2004,33(3):321-327.
4Sun X,Peterson LC,Gong Y,et al.Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients[J].Mod Pathol,2004,17 (4):389-394.
5Fabbian F,Tessari G,Colato C,et al.Cutaneous plasmacytoma in a hemodialysis patient[J].Int J Artif Organs,2004,27 (10):907-909.
6Rajakariar R,Bhattacharyya M,Norton A,et al.Post transplant T-cell lymphoma:a case series of four patients from a single unit and review of the literature[J].Am J Transplant,2004,4 (9):1534-1538.
7Lucioni M,Ippoliti G,Campana C,et al.EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient:case report[J].Am J Transplant,2004,4 (11):1915-1920.
8Ranganathan S,Webber S,Ahuja S,et al.Hodgkin-like posttransplant lymphoproliferative disorder in children:does it differ from posttransplant Hodgkin lymphoma[J]? Pediatr Dev Pathol,2004,7 (4):348-360.
9Choquet S,Mamzer BM,HermineO,et al.Identification of prognostic factors in post-transplant lymphoproliferative disorders[J].Recent Results Cancer Res,2002,159:67-80.
10Airoldi A,Alberti A,Bonacina E,et al.Epstein-Barr virus (EBV)load and interleukin-10 in EBV-positive and EBV-negative posttransplant lymphoproliferative disorders[J].Br J Haematol,2003,122(6):927-933.
